Skip to content

Research

All Research Featured Research

Read: Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”

Comment Letter

Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”

October 21, 2025

Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD

Read: USC Health Economist Darius Lakdawalla Elected to National Academy of Medicine

News

USC Health Economist Darius Lakdawalla Elected to National Academy of Medicine

October 20, 2025

Featured Experts: Darius Lakdawalla, PhD

Read: Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness

Journal Article

Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness

September 5, 2025

Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Maria-Alice Manetas, Darius Lakdawalla, PhD

Read: Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare

Journal Article

Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare

July 11, 2025

Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD

Read: Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation

Comment Letter

Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation

June 27, 2025

Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD

Read: Why Do Americans Pay More for Prescription Drugs?

News

Why Do Americans Pay More for Prescription Drugs?

June 12, 2025

Featured Experts: Darius Lakdawalla, PhD

Read: Leveraging Corporate Tax Rates, Rather Than R&D Credits or Tariffs, Is Key to Supporting U.S. Biomedical Innovation

News

Leveraging Corporate Tax Rates, Rather Than R&D Credits or Tariffs, Is Key to Supporting U.S. Biomedical Innovation

June 4, 2025

Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Darius Lakdawalla, PhD

Read: How Does Corporate Tax Policy Influence Innovation?

White Paper

How Does Corporate Tax Policy Influence Innovation?

June 4, 2025

Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Darius Lakdawalla, PhD

Read: Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us

Perspective

Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us

May 20, 2025

Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD

Read: ‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems

Perspective

‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems

April 14, 2025

Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD

Read: Care Continuity, Nephrologists’ Dialysis Facility Preferences, and Outcomes

Journal Article

Care Continuity, Nephrologists’ Dialysis Facility Preferences, and Outcomes

April 11, 2025

Featured Experts: Eugene Lin, MD, MS, Khristina Ipapo Lung, MPH, Darius Lakdawalla, PhD, Desi Peneva, MS, Karen Van Nuys, PhD

Read: Lifetime Social Returns From Expanding Access to Anti-Obesity Medications

White Paper

Lifetime Social Returns From Expanding Access to Anti-Obesity Medications

March 27, 2025

Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD

Read: Expanding Access to Anti-Obesity Medications Delivers 13% Return on Investment for Society

News

Expanding Access to Anti-Obesity Medications Delivers 13% Return on Investment for Society

March 27, 2025

Featured Experts: Alison Sexton Ward, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH

Read: The Effect of US COVID-19 Excess Mortality on Social Security Outlays

Journal Article

The Effect of US COVID-19 Excess Mortality on Social Security Outlays

February 18, 2025

Featured Experts: Hanke Heun-Johnson, PhD, Darius Lakdawalla, PhD, Bryan Tysinger, PhD

Read: Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues

News

Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues

February 18, 2025

Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD

Read: The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?

White Paper

The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?

February 18, 2025

Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD

Read: Medicare Drug Price Negotiations Need Something New: A Floor

Perspective

Medicare Drug Price Negotiations Need Something New: A Floor

January 22, 2025

Featured Experts: Darius Lakdawalla, PhD

Read: Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures

Comment Letter

Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures

August 8, 2024

Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD

Read: A Patient-Focused, Evidence-Driven Approach to PBM Reform

Evidence Base

A Patient-Focused, Evidence-Driven Approach to PBM Reform

July 22, 2024

Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD, Stephanie Hedt, MPP, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Neeraj Sood, PhD, Erin Trish, PhD

Read: Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations

Comment Letter

Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations

July 18, 2024

Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD

1
2
3
4
…
6
7
8
Next →